China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong
· Delayed Price · Currency is HKD 4.920
-0.010 (-0.20%)
Apr 29, 2025, 4:08 PM HKT
HKG:3320 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | - | 3,854 | 3,500 | 3,070 | 2,776 | Upgrade
|
| Depreciation & Amortization | - | 3,164 | 2,558 | 2,299 | 2,058 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -63.85 | -334.84 | -7.83 | 15.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1,161 | 1,101 | 216.24 | 571.26 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 21.34 | -17.41 | -101.66 | -90.83 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -417.11 | -332.34 | -255.48 | -174.18 | Upgrade
|
| Stock-Based Compensation | - | 141.89 | 99.55 | 1.17 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 450.67 | 478.75 | 371.34 | 657.14 | Upgrade
|
| Other Operating Activities | - | 5,636 | 4,369 | 4,625 | 4,265 | Upgrade
|
| Change in Accounts Receivable | - | -6,077 | -6,441 | -3,851 | -4,239 | Upgrade
|
| Change in Inventory | - | -2,668 | -2,233 | -2,779 | -678.3 | Upgrade
|
| Change in Accounts Payable | - | 10,910 | 8,109 | 6,140 | 1,298 | Upgrade
|
| Change in Unearned Revenue | - | 279.44 | 704.95 | 728.41 | 482.7 | Upgrade
|
| Change in Other Net Operating Assets | - | -842.7 | -741.93 | 6.25 | -31.46 | Upgrade
|
| Operating Cash Flow | - | 15,550 | 10,821 | 10,462 | 6,910 | Upgrade
|
| Operating Cash Flow Growth | - | 43.70% | 3.43% | 51.41% | -5.05% | Upgrade
|
| Capital Expenditures | - | -2,523 | -2,279 | -1,967 | -1,406 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 176.95 | 73.05 | 117.08 | 79.94 | Upgrade
|
| Cash Acquisitions | - | - | - | -1,415 | -979.1 | Upgrade
|
| Divestitures | - | 39.85 | 422.15 | 190.72 | 797.06 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -476.91 | -302.51 | -490.28 | -310.13 | Upgrade
|
| Investment in Securities | - | -835.49 | 267.68 | -4,007 | 15.83 | Upgrade
|
| Other Investing Activities | - | 1,552 | 999.86 | 84.22 | -142.25 | Upgrade
|
| Investing Cash Flow | - | -2,067 | -819.24 | -7,487 | -1,898 | Upgrade
|
| Short-Term Debt Issued | - | - | 2,304 | 2,056 | 5,871 | Upgrade
|
| Long-Term Debt Issued | - | 85,184 | 88,175 | 74,444 | 46,384 | Upgrade
|
| Total Debt Issued | - | 85,184 | 90,479 | 76,500 | 52,255 | Upgrade
|
| Short-Term Debt Repaid | - | -5,213 | - | -1,794 | -7,538 | Upgrade
|
| Long-Term Debt Repaid | - | -82,426 | -93,884 | -69,769 | -47,136 | Upgrade
|
| Total Debt Repaid | - | -87,639 | -93,884 | -71,563 | -54,674 | Upgrade
|
| Net Debt Issued (Repaid) | - | -2,455 | -3,405 | 4,937 | -2,418 | Upgrade
|
| Repurchase of Common Stock | - | - | -3,018 | - | -8.02 | Upgrade
|
| Common Dividends Paid | - | -879.97 | -813.07 | -614.18 | -581.91 | Upgrade
|
| Other Financing Activities | - | -730.22 | -1,890 | -1,875 | -2,393 | Upgrade
|
| Financing Cash Flow | - | -4,065 | -9,126 | 2,448 | -5,401 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 9.66 | 31.92 | -295.47 | -718.94 | Upgrade
|
| Net Cash Flow | - | 9,427 | 907.75 | 5,128 | -1,109 | Upgrade
|
| Free Cash Flow | - | 13,027 | 8,542 | 8,495 | 5,504 | Upgrade
|
| Free Cash Flow Growth | - | 52.51% | 0.55% | 54.34% | -5.15% | Upgrade
|
| Free Cash Flow Margin | - | 5.32% | 3.91% | 4.40% | 3.26% | Upgrade
|
| Free Cash Flow Per Share | - | 2.07 | 1.36 | 1.35 | 0.88 | Upgrade
|
| Cash Interest Paid | - | 2,644 | 1,937 | 2,164 | 2,401 | Upgrade
|
| Cash Income Tax Paid | - | 2,307 | 2,222 | 1,640 | 1,260 | Upgrade
|
| Levered Free Cash Flow | - | 1,765 | 8,338 | -2,434 | -2,096 | Upgrade
|
| Unlevered Free Cash Flow | - | 3,242 | 9,855 | -1,053 | -446.34 | Upgrade
|
| Change in Net Working Capital | 24,245 | 3,965 | -3,691 | 5,908 | 5,702 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.